Fulgent Genetics (FLGT) Income from Non-Controlling Interests (2021 - 2026)
Fulgent Genetics' (FLGT) quarterly Income from Non-Controlling Interests came in at -$448000.0 in Q1 2026, down 21.41% year-on-year from -$570041.4 in Q1 2025, and down 93.1% quarter-over-quarter from -$232000.0 in Q4 2025.
Fulgent Genetics (FLGT) Income from Non-Controlling Interests (2021 - 2026) Analysis & Trends
Fulgent Genetics has disclosed Income from Non-Controlling Interests across 6 years of filings, most recently posting -$448000.0 for Q1 2026.
- Income from Non-Controlling Interests for Q1 2026 came in at -$448000.0, down 21.41% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.2 million (down 9.12% YoY), and the FY2025 annual result was -$1.1 million, down 0.54% from the prior year.
- Income from Non-Controlling Interests came in at -$448000.0 for Q1 2026 at Fulgent Genetics, down from -$232000.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of -$46000.0 in Q3 2024 to a low of -$6.2 million in Q4 2023.
- The 5-year median for Income from Non-Controlling Interests is -$369000.0 (2025), against an average of -$680705.9.
- Across the five-year window, Income from Non-Controlling Interests tumbled 2434.84% in 2023 and jumped 95.12% in 2024, its largest moves.
- Fulgent Genetics' Income from Non-Controlling Interests stood at -$244000.0 in 2022, then sank by 2434.84% to -$6.2 million in 2023, then surged by 95.12% to -$302000.0 in 2024, then rose by 23.18% to -$232000.0 in 2025, then sank by 93.1% to -$448000.0 in 2026.
- The last three Income from Non-Controlling Interests figures came in at -$448000.0 (Q1 2026), -$232000.0 (Q4 2025), and -$218000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 5.00 Mn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | - |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 1.00 Mn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | - |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | - |
| 10 | Fulgent Genetics | 584.27 Mn | 302.31 Mn | 21.49 Mn | -448,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -448,000.00 |
| Dec 31, 2025 | -232,000.00 |
| Sep 30, 2025 | -218,000.00 |
| Jun 30, 2025 | -299,000.00 |
| Mar 31, 2025 | -369,000.00 |
| Dec 31, 2024 | -302,000.00 |
| Sep 30, 2024 | -46,000.00 |
| Jun 30, 2024 | -380,000.00 |
| Mar 31, 2024 | -384,000.00 |
| Dec 31, 2023 | -6.19 Mn |
| Sep 30, 2023 | -359,000.00 |
| Jun 30, 2023 | -361,000.00 |
| Mar 31, 2023 | -509,000.00 |
| Dec 31, 2022 | -244,000.00 |
| Sep 30, 2022 | -376,000.00 |
| Jun 30, 2022 | -438,000.00 |
| Mar 31, 2022 | -422,000.00 |
| Dec 31, 2021 | -662,000.00 |
| Sep 30, 2021 | -298,000.00 |
| Jun 30, 2021 | -165,000.00 |